Search Reports:
  Search
spacer
MORE INFORMATIONarrow
Not sure this is the report that you need? Have questions about the report before purchasing? We're here to help!
HOW TO ORDERarrow
Ordering reports couldn't be easier. Select the license for your needs, click Order Now, and complete our streamlined checkout process. We accept major credit cards, wire/bank transfers, and checks.

MC, Visa, AMEX, Diners, Discovery, JCB
MORE OPTIONSarrow
ABOUT THE PUBLISHERarrow
GlobalData is a leading provider of global business intelligence including market, competitor, product and customer information. It provides in-depth research, analysis, data and forecasts through a range of interactive online databases, reports and management briefings. GlobalData has a large team of experienced research and analysis, consulting, and marketing experts. It has a global presence, including key offices in the US, Europe and Asia. The group has over 50 years of experience of delivering market intelligence data and analysis and a highly experienced senior management team.

Alafair Biosciences, Inc. - Product Pipeline Analysis, 2013 Update

Published by GlobalData on Dec 31, 2013 - 19 pages
PDF format - Delivered by Email within 1 business day
License Options Question


Report Abstract Table of Contents Companies Mentioned Request Sample
Alafair Biosciences, Inc. (Alafair) is a life science company. The company develops cross-linked polysaccharide hydrogel films to address the post-surgical complication of unwanted soft tissue attachments, and tethering between opposing tissue surfaces. It offers film product which shows superior handling and mechanical properties. Alafair's product pipeline includes membrane, bilayer, and injectable gel solutions for applications in scar prevention, wound care, and tissue reconstruction. The company's medical products utilize a hydrogel platform. Its technologies are available to support the needs of surgeons in minimally-invasive, laparoscopic, and robotic surgeries, and are a revolutionary solution for internal wound healing. Alafair is headquartered in Austin, Texas, the US.

This report is a source for data, analysis and actionable intelligence on the Alafair Biosciences, Inc. portfolio of pipeline products. The report provides detailed analysis on each pipeline product with information on the indication, the development stage, trial phase, product milestones, pipeline territory, estimated approval date, and estimated launch date.

Each pipeline product is profiled to cover information on product description, function, technology, indication, and application. The report is also supplemented with a detailed company profile and information on clinical trials, wherever applicable.

This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

Scope
  • Detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments.<\li>
  • Detailed coverage on all the pipeline products, by equipment type, by therapy area, by development stage, and by trial phase.<\li>
  • Information on product milestones and pipeline territory for each product, the estimated approval date, and estimated launch date.<\li>
  • Profile of each pipeline product with additional information on product description, function, technology, indication(s), and application.<\li>
  • Data on relevant clinical trials and product patent details, wherever applicable.<\li>
  • Information on clinical trial, wherever applicable, is supplemented with information on trial phase, trial status, trial objective, trial design, target patients, unique physician identifier, primary point, secondary point, acronym, participants inclusion, participants exclusion, interventions, trial results, trial start date, trial end date, study type, trial site, trial funding, age eligibility, and gender eligibility.
Reasons to Buy
  • Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape globally.<\li>
  • Design and develop your product development, marketing and sales strategies.<\li>
  • Exploit M&A opportunities by identifying market players with the most innovative pipeline.<\li>
  • Develop market-entry and market expansion strategies.<\li>
  • Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return.<\li>
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage.<\li>
  • Develop competition strategies by identifying the status and likely launch of your competitors' pipeline products through review of the clinical trials, stage and phase of development, etc.<\li>
  • Which are the next high-value products that your competitor would add in its portfolio? - identify, understand and capitalize.






Copyright © 2014 Fast Market Research, Inc.